Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
Read More »overdone
Shidlovski Baird said it thinks recent weakness in Ocular Therapeutix (NASDAQ:OCUL) shares is “overdone” and remains bullish on the company’s…
Read More »